Salvage radical prostatectomy

Curr Opin Urol. 2023 Mar 1;33(2):163-167. doi: 10.1097/MOU.0000000000001074. Epub 2022 Dec 29.

Abstract

Purpose of review: Salvage radical prostatectomy (sRP) is underutilized because of fear of historical high rates of peri-operative morbidities. However, there has been significant improvements in complication rates as well as oncologic outcomes in the recent years.

Recent findings: Complication rates have significantly declined for both open and robotic approach in the past decade. Rectal injury is now reported around 2%, which is down from 30% in the historic series. Similarly, the current risk of major vascular injury is low. About 75% of patients report social continence (up to one pad per day). However, erectile function recovery remains poor and patients should be counselled accordingly. Long-term durable oncologic response is achievable with 10-year recurrence-free survival reported in about 40-50% of well selected patients.

Summary: Recent improvements in oncologic and peri-operative outcomes make sRP a desirable option for local control. sRP treats the whole gland as opposed to focal therapies and allows for pelvic lymph node dissection and removal of seminal vesicles, which can be sanctuary site of disease. In experienced hands, regardless of the surgical approach, sRP can achieve a durable response resulting in delaying or avoiding androgen deprivation therapy and its associated morbidities.

Publication types

  • Review

MeSH terms

  • Androgen Antagonists
  • Humans
  • Male
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / prevention & control
  • Prostatectomy / adverse effects
  • Prostatectomy / methods
  • Prostatic Neoplasms* / surgery
  • Salvage Therapy / methods
  • Seminal Vesicles* / pathology
  • Treatment Outcome

Substances

  • Androgen Antagonists